Telix Pharmaceuticals Limited (TLX) vs Xenon Pharmaceuticals Inc. (XENE)

Telix Pharmaceuticals Limited and Xenon Pharmaceuticals Inc. are both Biotechnology companies. Telix Pharmaceuticals Limited and Xenon Pharmaceuticals Inc. are of similar size ($3.9B and $3.7B). Across the 8 metrics below, Telix Pharmaceuticals Limited leads on 4 and Xenon Pharmaceuticals Inc. on 4.

Valuation

Metric TLX XENE Biotechnology median
P/E — n/m 7.88
P/S — 217.29 11.47
P/B n/m 2.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 162.98 10.73
Earnings yield — (12.83%) (28.84%)
Free cash flow yield 0.00% (9.20%) (23.03%)

Profitability

Metric TLX XENE Biotechnology median
Gross margin — 28.40% 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (43.62%) (57.72%)
Return on assets 0.00% (41.54%) (49.22%)
Return on invested capital 0.00% (88.54%) 0.00%

Growth

Metric TLX XENE Biotechnology median
Revenue growth (TTM) — (8.15%) 5.64%
EPS growth (last fiscal year) (120.00%) (44.85%) —
Revenue growth, 5-year CAGR — 89.00% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric TLX XENE Biotechnology median
Debt to equity 1.18 0.00 0.00
Current ratio 2.01 21.02 4.73
Net debt to EBITDA 6.25 1.48 0.96

Dividend

Metric TLX XENE Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric TLX XENE Biotechnology median
Market cap 3.86b 3.73b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack